Hymecromone

羟甲香豆素

Report date: 2025/03/18 14:31:24
NME

Base Information

Drug NameHymecromone
Drug Alias Name羟甲氧色烯himecromonahymecromonum4-MethylumbelliferoneCantabiline +[12] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSpasmIdiopathic Pulmonary FibrosisLung Diseases, Interstitial +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesStanford University
China Registration ClassN/A

Develop Information

Active CompaniesStanford UniversityNational Institute Of Environmental Health Sciences (Niehs)
Inactive CompaniesMtmedical Institute Of Health
Active IndicationsSpasmIdiopathic Pulmonary FibrosisLung Diseases, Interstitial +[5] 
Inactive IndicationsHepatitis C, ChronicHepatitis B, Chronic

Other Information

ATC CodeA05AX02
Related LinksWikipediaKEGG